Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
Morolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug dev...
Furkejuvvon:
Váldodahkki: | |
---|---|
Eará dahkkit: | , , , , |
Materiálatiipa: | article |
Almmustuhtton: |
2020
|
Fáttát: | |
Liŋkkat: | https://doi.org/10.1002/bit.27357 http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360 |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
_version_ | 1840044847660007424 |
---|---|
author | Srisawat, Pisanee |
author2 | Yasumoto, Shuhei Fukushima, Ery Odette Robertlee, Jekson Seki, Hikaru Muranaka, Toshiya |
author2_role | author author author author author |
author_facet | Srisawat, Pisanee Yasumoto, Shuhei Fukushima, Ery Odette Robertlee, Jekson Seki, Hikaru Muranaka, Toshiya |
author_role | author |
collection | Repositorio Universidad Regional Amazónica |
dc.creator.none.fl_str_mv | Srisawat, Pisanee Yasumoto, Shuhei Fukushima, Ery Odette Robertlee, Jekson Seki, Hikaru Muranaka, Toshiya |
dc.date.none.fl_str_mv | 2020-06-02T20:32:53Z 2020-06-02T20:32:53Z 2020 |
dc.format.none.fl_str_mv | application/pdf |
dc.identifier.none.fl_str_mv | Srisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357 https://doi.org/10.1002/bit.27357 http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360 |
dc.language.none.fl_str_mv | en |
dc.publisher.none.fl_str_mv | Wiley - V C H Verlag GmbbH & Co. |
dc.relation.none.fl_str_mv | PRODUCCIÓN CIENTÍFICA-ARTÍCULOS;A-IKIAM-000030 |
dc.rights.none.fl_str_mv | Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América http://creativecommons.org/licenses/by-nc-nd/3.0/us/ info:eu-repo/semantics/openAccess |
dc.source.none.fl_str_mv | reponame:Repositorio Universidad Regional Amazónica instname:Universidad Regional Amazónica instacron:IKIAM |
dc.subject.none.fl_str_mv | bioactive plant morolic acid derived triterpenoid |
dc.title.none.fl_str_mv | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
dc.type.none.fl_str_mv | info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
description | Morolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug development research, but the low accessibility of morolic acid from natural resources limits its applications. In the present study, we developed a microbial system for the production of morolic acid. Using a combinatorial biosynthesis approach, a novel production pathway was constructed in Saccharomyces cerevisiae by co‐expressing BfOSC2 (germanicol synthase) from Bauhinia forficata and CYP716A49 (triterpene C‐28 oxidase) from Beta vulgaris. Moreover, we reconstructed the cellular galactose regulatory network by introducing a chimeric transcriptional activator (fusion of Gal4dbd.ER.VP16, GEV) to overdrive the genes under the control of the galactose promoter. We also overexpressed truncated HMG1, encoding feedback‐inhibition‐resistant form of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase 1 and sterol‐regulating transcription factor upc2‐1, to increase the isoprenoid precursors in the mevalonate pathway. Using this yeast system, we achieved morolic acid production up to 20.7 ± 1.8 mg/L in batch culture. To our knowledge, this is the highest morolic acid titer reported from a heterologous host, indicating a promising approach for obtaining rare natural triterpenoids. This article is protected by copyright. All rights reserved. |
eu_rights_str_mv | openAccess |
format | article |
id | IKIAM_5a2e86eaa69bccdd819abc68e8b5b750 |
identifier_str_mv | Srisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357 |
instacron_str | IKIAM |
institution | IKIAM |
instname_str | Universidad Regional Amazónica |
language_invalid_str_mv | en |
network_acronym_str | IKIAM |
network_name_str | Repositorio Universidad Regional Amazónica |
oai_identifier_str | oai:repositorio.ikiam.edu.ec:RD_IKIAM/360 |
publishDate | 2020 |
publisher.none.fl_str_mv | Wiley - V C H Verlag GmbbH & Co. |
reponame_str | Repositorio Universidad Regional Amazónica |
repository.mail.fl_str_mv | . |
repository.name.fl_str_mv | Repositorio Universidad Regional Amazónica - Universidad Regional Amazónica |
repository_id_str | 0 |
rights_invalid_str_mv | Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América http://creativecommons.org/licenses/by-nc-nd/3.0/us/ |
spelling | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiaeSrisawat, PisaneeYasumoto, ShuheiFukushima, Ery OdetteRobertlee, JeksonSeki, HikaruMuranaka, Toshiyabioactive plantmorolic acidderived triterpenoidMorolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug development research, but the low accessibility of morolic acid from natural resources limits its applications. In the present study, we developed a microbial system for the production of morolic acid. Using a combinatorial biosynthesis approach, a novel production pathway was constructed in Saccharomyces cerevisiae by co‐expressing BfOSC2 (germanicol synthase) from Bauhinia forficata and CYP716A49 (triterpene C‐28 oxidase) from Beta vulgaris. Moreover, we reconstructed the cellular galactose regulatory network by introducing a chimeric transcriptional activator (fusion of Gal4dbd.ER.VP16, GEV) to overdrive the genes under the control of the galactose promoter. We also overexpressed truncated HMG1, encoding feedback‐inhibition‐resistant form of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase 1 and sterol‐regulating transcription factor upc2‐1, to increase the isoprenoid precursors in the mevalonate pathway. Using this yeast system, we achieved morolic acid production up to 20.7 ± 1.8 mg/L in batch culture. To our knowledge, this is the highest morolic acid titer reported from a heterologous host, indicating a promising approach for obtaining rare natural triterpenoids. This article is protected by copyright. All rights reserved.Wiley - V C H Verlag GmbbH & Co.2020-06-02T20:32:53Z2020-06-02T20:32:53Z2020info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfSrisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357https://doi.org/10.1002/bit.27357http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360enPRODUCCIÓN CIENTÍFICA-ARTÍCULOS;A-IKIAM-000030Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de Américahttp://creativecommons.org/licenses/by-nc-nd/3.0/us/info:eu-repo/semantics/openAccessreponame:Repositorio Universidad Regional Amazónicainstname:Universidad Regional Amazónicainstacron:IKIAM2023-04-04T08:00:17Zoai:repositorio.ikiam.edu.ec:RD_IKIAM/360Institucionalhttps://repositorio.ikiam.edu.ec/Universidad públicahttps://www.ikiam.edu.ec/https://repositorio.ikiam.edu.ec/oaiEcuador...opendoar:02023-04-04T08:00:17falseInstitucionalhttps://repositorio.ikiam.edu.ec/Universidad públicahttps://www.ikiam.edu.ec/https://repositorio.ikiam.edu.ec/oai.Ecuador...opendoar:02023-04-04T08:00:17Repositorio Universidad Regional Amazónica - Universidad Regional Amazónicafalse |
spellingShingle | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae Srisawat, Pisanee bioactive plant morolic acid derived triterpenoid |
status_str | publishedVersion |
title | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
title_full | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
title_fullStr | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
title_full_unstemmed | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
title_short | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
title_sort | Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae |
topic | bioactive plant morolic acid derived triterpenoid |
url | https://doi.org/10.1002/bit.27357 http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360 |